Clinical Report: Decline in Coronary Artery Disease Mortality Indicates Potential for Further Improvements

Overview

Ischemic heart disease deaths in the U.S. fell by over 50% from 1990 to 2023, largely due to better management of risk factors. Nearly 90% of recent deaths remain linked to modifiable risk factors.

Background

Coronary artery disease is a leading cause of mortality globally. Despite notable declines in mortality rates, the persistence of preventable deaths highlights ongoing challenges in public health and clinical practice.

Data Highlights

No numerical data table available.

Key Findings

• Deaths from ischemic heart disease decreased by more than 50% from 1990 to 2023.
• 88.8% of coronary artery disease deaths in 2023 were linked to modifiable risk factors.
• High blood pressure, poor diet, and high LDL cholesterol were the leading contributors to heart disease mortality.
• States with tobacco control policies saw greater improvements in heart disease mortality rates.
• Higher body mass index and blood glucose levels have increased since 1990.

Clinical Implications

Healthcare professionals should focus on the management of modifiable risk factors in patients.

Conclusion

Progress has been made in reducing coronary artery disease mortality, but opportunities remain to decrease preventable deaths.

Related Resources & Content

1. Gregory A. Roth, GBD Collaborators, Modifiable risk factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023
2. European Journal of Preventive Cardiology, The Prospects of Cardiovascular Disease: A Turning Point or Continued Challenge?
3. European Journal of Preventive Cardiology, Therapies leading to coronary atherosclerosis plaque regression
4. Frontiers in Cardiovascular Medicine, Editorial: Clinical Trials in Cardiovascular Medicine: 2025
5. Clinical Research in Cardiology — Impact of Renin-Angiotensin System Inhibitors on Long-Term Mortality After Percutaneous Coronary Intervention in Patients with Varying Ejection Fractions
6. Modifiable risk factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023 by Gregory A. Roth, GBD Collaborators, Benjamin Stark :: SSRN
7. Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
8. 2025 High Blood Pressure Guideline - Professional Heart Daily | American Heart Association